SEARCH RESULT

Total Matching Records found : 171

India’s drug ‘lifeline’ under threat by Mari Marcel Thekaekara

I never dreamed I’d ever wave the flag for Indian pharmaceutical companies. But some years ago, I discovered that India provides essential drugs to most of the world’s economically deprived nations. Many of the poorest people in India and Africa could not afford basic drugs if it were not for Indian drug companies. Astonishingly, India is known as the ‘pharmacy to the developing world’ and is something of a hero in...

More »

Human Smears by Madhavi Tata

Poor Andhra villagers now victims of clinical drug trials No Drug Resistance     * 35 women, some men from Guntur district put throughclinical trials of a breast cancer drug. They later complain of joint pains, nausea and chest pains.     * Biotech industry in Andhra is worth about Rs 455 crore     * Touts operating on behalf of pharma companies get people from the poorer districts to Hyderabad for the tests *** Some 35 women...

More »

Gene card to tell what drugs to avoid by GS Mudur

Scientists have launched a project to develop India’s first personal genetic data cards — credit card-sized plastic-and-magnetic devices that could dramatically expand access to personalised predictive medicine. In its first phase, the project will capture genetic data to predict a person’s likely response to more than 100 drugs to help him avoid taking medicines that may not benefit him or may cause him serious side-effects. Scientists also hope to use genetic data...

More »

Patients rally against trade pact with EU

Patients battling cancer, infections and mental illness joined a rally here today beseeching the government to reject a trade pact with the European Union that they fear will threaten the availability of inexpensive generic medicines in India. An estimated 2,000 people, many among them infected with HIV, walked along Delhi’s Parliament Street on a day when Indian and EU officials were negotiating a free trade agreement in Brussels. Health activists and lawyers...

More »

HIV patients say ‘no' to IP provision on generic drugs by Aarti Dhar

‘It will hinder access to quality, affordable generic medicines produced in India' People in Asia living with HIV and who depend on affordable generic AIDS medicines to stay alive have impressed upon the Indian government to stand strong against European Union demands on the sensitive Intellectual Property (IP) chapter in ongoing Free Trade Agreement (FTA) negotiations. The EU is pushing for harmful IP provisions to be included in the trade agreement...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close